The proposal of United Kingdom-based firm AstraZeneca to hold COVID-19 vaccine clinical trials in the Philippines is now up for the final stage of assessment, according to an official from the Department of Science and Technology.
Dr. Jaime Montoya, executive director of the DOST-Philippine Council for Health Research and Development, told CNN Philippines’ News Night on Wednesday that AstraZeneca’s application is already with the Food and Drug Administration for regulatory approval after it passed the Ethics Review Board.
The UK company is applying for Phase 3 of vaccine clinical trials in the country. Under this phase, a vaccine is tested on larger populations in different countries to confirm its efficacy and safety.
Earlier, Health Secretary Francisco Duque III said the AstraZeneca vaccine will still have to undergo “stringent analysis” with health authorities even after it secured a deal for the supply of around 2.6 million doses of COVID-19 vaccine to the Philippines.